title: Manufacturers' promotion of off-label drug use: implications for drug safety.
authors.affiliation: a Litigation Group , Public Citizen , Washington , DC , USA.
authors.forename: Allison
authors.initials: A
authors.lastname: Zieve
authors.affiliation: b Health Research Group , Public Citizen , Washington , DC , USA.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Carome
mesh_terms: D000329:Advertising / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D056687:Off-Label Use / Q000331:legislation & jurisprudence*; D055553:Prescription Drugs / Q000009:adverse effects* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D055553:Prescription Drugs
keywords: Drug safety; First Amendment; Food and Drug Administration; off-label promotion